● In Stock
Glow
≥99% Purity | HPLC Verified
$100.00
PASSED
Sterility & Endotoxins
PASSED
Net Content & Purity
Purity:
≥99%
Store at
-20°C
GHK-Cu and BPC-157 research stack studied for skin collagen synthesis and tissue regeneration. Research use only.
| Strength | 70mg |
| Purity | >99% (HPLC) |
| Form | Lyophilized Powder |
3
Pathways
VEGF + Actin + Collagen synergy
7×
GHR Upregulation
BPC-157 by day 3
70%
Collagen Increase
GHK-Cu vs controls
61%
Faster Healing
TB-500 re-epithelialization
Science Overview
How GLOW Works
The Science, Simplified
BPC
VEGF Pathway Primary
Vascular Endothelial Growth Factor (BPC-157)
- Promotes blood vessel formation
- Enhances tissue granulation
- Modulates nitric oxide signaling
TB4
Actin Regulation Primary
Thymosin Beta-4 Pathway (TB-500)
- Increases cell migration
- Supports cytoskeletal remodeling
- Reduces fibrotic scarring
Cu
Collagen & ECM Primary
Copper Peptide Signaling (GHK-Cu)
- Stimulates type I & III collagen
- Modulates 4,000+ genes
- Delivers copper to repair sites
Why Three Peptides Work Together
Complementary Regeneration
Each peptide in GLOW addresses a different phase of tissue repair. BPC-157 initiates vascular support and blood flow to damaged areas. TB-500 mobilizes repair cells through enhanced migration. GHK-Cu stimulates collagen synthesis and modulates thousands of repair genes.
Tydes Research (2025): The combination targets angiogenesis, cellular migration, and ECM remodeling simultaneously — three complementary mechanisms that individually have 200+, 170+, and 130+ preclinical publications respectively.
BPC-157 (Angiogenesis)↑ VEGF Pathway
TB-500 (Cell Migration)↑ Actin Regulation
GHK-Cu (Collagen)↑ ECM Remodeling
Combined Pathways3 Mechanisms
Research Source
GLOW Peptide Blend Research Overview
The synergistic combination of BPC-157, TB-500, and GHK-Cu targets distinct but complementary regenerative mechanisms in preclinical tissue repair models. Each component contributes to overlapping phases of the wound healing and regeneration cascade.
Tydes Research (2025): Mechanistic analysis of the GLOW blend across angiogenic, migratory, and matrix remodeling pathways in preclinical tissue models.
Phase 1: Blood FlowBPC-157
Phase 2: Cell MobilizationTB-500
Phase 3: Matrix RebuildGHK-Cu
Synergy PotentialEmerging Research
Research Data
What Researchers Observed
Combined preclinical data from component peptides
3x
Pathways Targeted Simultaneously
GLOW engages angiogenesis, cell migration, and ECM remodeling in parallel — three mechanisms that individually have 500+ combined publications in preclinical models.
Multi-Study Analysis • 500+ Publications
9x
Increased collagen in wounds
GHK-Cu with PIC treatment
7x
GHR upregulation by day 3
BPC-157 in tendon fibroblasts
61%
Faster re-epithelialization
TB-500 vs controls at 7 days
Key Metrics by Component
Research note: These findings are from individual peptide studies. Combination effects are based on mechanistic synergy, not direct clinical trials of the blend. Data aggregated from individual peptide studies in animal models: BPC-157: 200+ studies, TB-500: 170+ studies, GHK-Cu: 130+ studies.
Applications
Research Applications
Areas studied in preclinical models
Skin
Regeneration
GHK-Cu promotes collagen synthesis, while BPC-157 and TB-500 support epithelial repair and reduce scarring
Tissue
Repair
TB-500 facilitates actin remodeling; BPC-157 promotes tendon fibroblast viability; GHK-Cu supports vascular stabilization
Anti-
Inflammatory
All three peptides demonstrate anti-inflammatory properties through different mechanisms in animal models
ECM
Remodeling
Coordinated extracellular matrix deposition and degradation for functional, less fibrotic tissue regeneration
Dermatological
Skin & Aesthetic Research
The GLOW blend is studied in preclinical skin models for effects on dermal remodeling, wound closure, and barrier restoration. GHK-Cu promotes collagen synthesis while BPC-157 and TB-500 support epithelial repair.
Collagen synthesis↑ 70%
Gene modulation4,000+ genes
Wrinkle depth↓ in studies
Skin thickness↑ aged models
Musculoskeletal
Muscle & Tendon Repair
In musculoskeletal research, GLOW is applied to models involving soft tissue injuries, overuse syndromes, and post-surgical recovery. Each peptide contributes unique repair mechanisms.
Protective
Anti-Inflammatory & Antioxidant
All three peptides demonstrate anti-inflammatory and antioxidant properties. GHK-Cu chelates free copper ions and downregulates TNF-α/IL-6. BPC-157 stabilizes nitric oxide pathways. TB-500 modulates macrophage activity.
3x
Anti-inflammatory pathways
Net effect: A more controlled inflammatory environment conducive to healing rather than chronic inflammation.
Neurovascular
Nerve & Vascular Interface
An emerging research area explores the blend’s potential for peripheral nerve regeneration. TB-500 and BPC-157 contribute to endothelial repair, while GHK-Cu supports capillary growth and tissue perfusion.
Endothelial repairTB-500 + BPC-157
Capillary growthGHK-Cu + BPC-157
Tissue perfusionAll three peptides
Safety Data
Safety Profile from Research
What preclinical studies report for each component
Each peptide in the GLOW blend has been individually studied for safety. BPC-157 has shown no LD50 in toxicity studies. TB-500 and GHK-Cu are well-tolerated in animal models. Combined effects require further investigation.
Reported Events
Preclinical Safety Summary
BPC-157No LD50 found
TB-500Well-tolerated
GHK-CuSafe topical use history
- Individual peptides have favorable safety profiles in research
- Combination safety requires specific investigation
- Human clinical data is limited for all three peptides
Important Considerations
Regulatory Status
- BPC-157: Investigational, preclinical research compound
- TB-500: Investigational, WADA prohibited substance (S0 category)
- GHK-Cu: Cosmetic ingredient with research applications
- No FDA approval for any therapeutic indication
- Research compound — not for human therapeutic use
- Not studied in pregnancy or lactation
Technical Data
Compound Information
Technical specifications for each component
Component Profiles
What Is In GLOW?
BPC-15715 amino acids, 1,419 Da
TB-50043 amino acids, 4,963 Da
GHK-Cu3 amino acids + Cu², 403 Da
Total peptides3 distinct compounds
MechanismsComplementary pathways
Storage Requirements
Stability Information
Lyophilized powder
-20°C for long-term storage
After reconstitution
2–8°C, use within 7 days
Light protection
Store away from direct light
Research Status
Where Each Stands
BPC-157: Preclinical
TB-500: Preclinical
GHK-Cu: Cosmetic + Research
TB-500: Preclinical
GHK-Cu: Cosmetic + Research
BPC-157 studies200+ publications
TB-500 studies170+ publications
GHK-Cu studies130+ publications
Combination studiesEmerging research
Common Questions
Frequently Asked Questions
Common questions about GLOW research
GLOW is a triple-peptide blend containing BPC-157 (a 15-amino acid gastric peptide), TB-500 (a 43-amino acid thymosin beta-4 fragment), and GHK-Cu (a copper tripeptide). Each peptide targets different but complementary regenerative mechanisms, making the combination relevant for multi-pathway tissue repair research.
The Wolverine Stack contains only BPC-157 and TB-500, focusing on angiogenesis and cell migration. GLOW adds GHK-Cu, which brings collagen synthesis, gene modulation (4,000+ genes), and copper delivery mechanisms. This third component extends the blend’s research applications to include skin regeneration, anti-aging pathways, and extracellular matrix remodeling.
Individually, these peptides have extensive preclinical research: BPC-157 has 200+ publications studying wound healing, GI protection, and tissue repair; TB-500 has 170+ publications on cell migration and musculoskeletal healing; GHK-Cu has 130+ publications on collagen synthesis, gene expression, and skin regeneration. Combination research is emerging but less extensive.
No. All three peptides are research compounds. BPC-157 and TB-500 are investigational peptides with no FDA approval and are banned by WADA. GHK-Cu is used in cosmetic formulations but is not approved as a therapeutic. GLOW is intended for laboratory and preclinical research applications only.
The three peptides target overlapping but distinct pathways: (1) Angiogenesis — BPC-157 (VEGF) and GHK-Cu (capillary growth) promote blood vessel formation; (2) Cell migration — TB-500 regulates actin for cellular movement; (3) ECM remodeling — GHK-Cu stimulates collagen while TB-500 reduces fibrosis; (4) Anti-inflammatory — all three modulate inflammatory mediators through different mechanisms.
Store lyophilized GLOW powder at -20°C for long-term stability. After reconstitution, refrigerate at 2–8°C and use within 7 days. Protect from direct light at all times. Do not freeze reconstituted solution.
GLOW is primarily studied for skin regeneration and dermal remodeling (GHK-Cu), musculoskeletal tissue repair (BPC-157 + TB-500), anti-inflammatory effects (all three), and emerging neurovascular research. The combination is particularly relevant to models involving multi-phase tissue repair where angiogenesis, cell migration, and ECM remodeling occur simultaneously.
Sources
Sources & References
Peer-reviewed research
Tydes Research
GLOW Peptide Blend: GHK-Cu, TB-500, and BPC-157 in Regenerative Research
2025 • View Source ↗
MDPI
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart & Margolina, 2018 • View Source ↗
Nature Scientific Reports
Thymosin Beta 4 and Cardiac Repair
Chi et al., 2017 • View Source ↗
J Applied Physiology
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing
Seiwerth et al., 2018 • View Source ↗
Published research on this compound is available through PubMed and other scientific databases.
Certificate of Analysis
| Analysis Date: | Available on request |
| Lot Number: | Batch-specific |
| Purity: | >99% (HPLC) |
Third-Party Testing
- ✓ Identity verification (Mass Spectrometry)
- ✓ Purity analysis (HPLC)
- ✓ Sterility testing
- ✓ Endotoxin screening
Storage Conditions
- Lyophilized: Store at -20°C, protected from light
- Reconstituted: Store at 2-8°C, use within 30 days
- Stability: 24 months from manufacture date when stored properly
Handling Guidelines
- Use sterile technique when reconstituting
- Allow vial to reach room temperature before opening
- Reconstitute with bacteriostatic water or sterile saline
- Avoid repeated freeze-thaw cycles
RESEARCH INSIGHTS
3D Structure
Glow
This compound has been extensively studied in peer-reviewed literature. Eon Peptides provides this product exclusively for legitimate in-vitro research and analytical applications.
- • High-purity research compound
- • Full analytical documentation included
- • Third-party verification available
PRODUCT SPECIFICATIONS
LOT DATA
| Lot Number | Assigned on shipment |
| Verified Purity | >99% |
| Quantity | 5mg |
MOLECULAR DATA
| Molecular Formula | Available on request |
| Form | Lyophilized Powder |
| Appearance | White to off-white powder |
Researchers who studied this also studied...
Related products
These products are intended for laboratory research purposes only, and are not for human or animal consumption.